Clinical Trial Update: Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a cancer vaccine for previously untreated or relapsed Follicular Lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Follicular Lymphoma | Phase 1 | Status: COMPLETED